Company Filing History:
Years Active: 2006-2011
Title: The Innovative Mind of Kenneth Francis Mace
Introduction
Kenneth Francis Mace, an inventor based in Fishers, Indiana, has made significant contributions in the field of medical treatments through his innovative work. With a total of three patents to his name, Mace demonstrates a commitment to advancing healthcare solutions, particularly in relation to glucagon-like insulinotropic peptides.
Latest Patents
Kenneth Mace's latest invention focuses on a chronic treatment regimen using glucagon-like insulinotropic peptides. This innovative method involves maintaining chronic steady-state serum levels of a GLP-1 compound within a specified range to effectively treat certain diseases. The potential of this treatment may pave the way for more effective management of conditions related to insulin regulation.
Career Highlights
Throughout his career, Kenneth has been associated with Eli Lilly and Company, a prominent player in the pharmaceutical industry. His work at this leading company underscores his role in the development of significant health innovations, reflecting his dedication to improving patient outcomes through research and development.
Collaborations
Kenneth is known to collaborate with talented colleagues, including Steven Witt Dodd and Michael Trautmann. These partnerships foster a creative environment that is essential for the innovative processes involved in medical research and patent development.
Conclusion
Kenneth Francis Mace continues to be an influential figure in the realm of medical innovations. His contributions, especially in treating diseases through advanced methodologies, highlight the importance of research and collaboration in the pharmaceutical industry. As he progresses further in his career, his innovative spirit and expertise are sure to lead to even more groundbreaking developments.